{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:10:56Z","timestamp":1786997456909,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202208310052"],"award-info":[{"award-number":["202208310052"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.thromres.2026.109587","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:24:13Z","timestamp":1768202653000},"page":"109587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Coagulation parameters in gastrointestinal cancer patients with venous thromboembolism"],"prefix":"10.1016","volume":"258","author":[{"given":"Dongyue","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lanting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mettine H.A.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araci M.R.","family":"Rondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri H.","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2026.109587_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/07357900802656681","article-title":"Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors","volume":"27","author":"Wun","year":"2009","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.thromres.2026.109587_bb0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109587_bb0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","article-title":"Venous thromboembolism and prognosis in cancer","volume":"125","author":"Khorana","year":"2010","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.thromres.2026.109587_bb0020","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2026.109587_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102101","article-title":"Variation in venous thromboembolism outcomes based on primary cancer site a RIETE registry analysis","volume":"4","author":"Trujillo-Santos","year":"2025","journal-title":"Jacc-Adv."},{"issue":"7","key":"10.1016\/j.thromres.2026.109587_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.thromres.2026.109587_bb0040","first-page":"95(","article-title":"The incidence of venous thromboembolism by type of solid cancer worldwide: a systematic review","author":"Harry","year":"2025","journal-title":"Cancer Epidemiol."},{"issue":"10","key":"10.1016\/j.thromres.2026.109587_bb0045","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2026.109587_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109587_bb0055","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1038\/nrdp.2015.6","article-title":"Venous thrombosis","volume":"1","author":"Wolberg","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"9","key":"10.1016\/j.thromres.2026.109587_bb0060","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"van Es","year":"2017","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.thromres.2026.109587_bb0065","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/jth.15503","article-title":"Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer","volume":"19","author":"Guman","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109587_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.thromres.2026.109587_bb0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0039-1687895","article-title":"Role of tissue factor in tumor progression and cancer-associated thrombosis","volume":"45","author":"Rondon","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109587_bb0080","article-title":"Systematic study of tissue factor expression in solid tumors","volume":"6","author":"de Bono","year":"2023","journal-title":"Cancer Rep. (Hoboken)"},{"issue":"29","key":"10.1016\/j.thromres.2026.109587_bb0085","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2009.22.6324","article-title":"Role of tissue factor in cancer","volume":"27","author":"Kasthuri","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109587_bb0090","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","article-title":"Microparticle-associated tissue factor activity: a link between cancer and thrombosis?","volume":"5","author":"Tesselaar","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109587_bb0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.thromres.2009.09.019","article-title":"Increased microparticle tissue factor activity in cancer patients with venous thromboembolism","volume":"125","author":"Manly","year":"2010","journal-title":"Thromb. Res."},{"issue":"22","key":"10.1016\/j.thromres.2026.109587_bb0100","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","article-title":"Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy","volume":"15","author":"Zwicker","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109587_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100123","article-title":"Mechanisms of cancer-associated thrombosis","volume":"7","author":"Hisada","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biom15010083","article-title":"Circulating, extracellular vesicle-associated tissue factor in cancer patients with and without venous thromboembolism","volume":"15","author":"Lami","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.thromres.2026.109587_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.03.001","article-title":"Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients","volume":"165","author":"Hisada","year":"2018","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2026.109587_bb0120","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","article-title":"Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients","volume":"10","author":"Thaler","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.thromres.2026.109587_bb0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin. Chem."},{"issue":"15","key":"10.1016\/j.thromres.2026.109587_bb0135","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2010.32.8294","article-title":"Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study","volume":"29","author":"Ay","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1078-0432.CCR-14-3358","article-title":"Soluble vascular endothelial growth factor (sVEGF) and the risk of venous thromboembolism in patients with cancer: results from the Vienna cancer and thrombosis study (CATS)","volume":"22","author":"Posch","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.thromres.2026.109587_bb0145","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1634\/theoncologist.2017-0530","article-title":"Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: the observational ROADMAP-CAT study","volume":"23","author":"Syrigos","year":"2018","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.thromres.2026.109587_bb0150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0043-1775856","article-title":"Thrombin generation markers as predictors of cancer-associated venous thromboembolism: a systematic review","volume":"50","author":"Gyldenholm","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/rth2.12161","article-title":"Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: an observational cohort study","volume":"3","author":"Chalayer","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109587_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207387","article-title":"Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: a sub-study of RASTEN - a randomized trial with low molecular weight heparin","volume":"13","author":"Gezelius","year":"2018","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.thromres.2026.109587_bb0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.13218","article-title":"Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment","volume":"14","author":"Reitter","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium\u2014role in regulation of coagulation and inflammation","volume":"34","author":"van Hinsbergh","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"8","key":"10.1016\/j.thromres.2026.109587_bb0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tem.2024.11.004","article-title":"Intracellular endothelial cell metabolism in vascular function and dysfunction","volume":"36","author":"Citrin","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2026.109587_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cobme.2017.12.001","article-title":"Thrombosis-on-a-chip: prospective impact of microphysiological models of vascular thrombosis","volume":"5","author":"Pandian","year":"2018","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.thromres.2026.109587_bb0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2018.04.009","article-title":"Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: a prospective cohort study","volume":"166","author":"van Es","year":"2018","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2026.109587_bb0190","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"5","key":"10.1016\/j.thromres.2026.109587_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102475","article-title":"Modeling cancer-associated hypercoagulability using glioblastoma spheroids in microfluidic chips","volume":"8","author":"Kapteijn","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109587_bb0205","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2026.109587_bb0210","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1538-7836.2009.03504.x","article-title":"Microparticle-associated tissue factor activity in cancer patients with and without thrombosis","volume":"7","author":"Tesselaar","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.thromres.2026.109587_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153839","article-title":"Tissue factor and extracellular vesicles: activation of coagulation and impact on survival in cancer","volume":"13","author":"Hisada","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH10-03-0187","article-title":"Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma","volume":"105","author":"Auwerda","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109587_bb0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/bjc.2016.170","article-title":"Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?","volume":"115","author":"Woei","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.thromres.2026.109587_bb0230","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/j.1538-7836.2008.03156.x","article-title":"Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer","volume":"6","author":"Khorana","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010100","article-title":"Thrombin generation and cancer: contributors and consequences","volume":"11","author":"Reddel","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.thromres.2026.109587_bb0240","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3324\/haematol.2020.253047","article-title":"Thrombin generation: a global coagulation procedure to investigate hypo- and hyper-coagulability","volume":"105","author":"Tripodi","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.thromres.2026.109587_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165390","article-title":"Tumor-specific D-dimer concentration ranges and influencing factors: a cross-sectional study","volume":"11","author":"Yu","year":"2016","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.thromres.2026.109587_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12536","article-title":"D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly","volume":"5","author":"Wang","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109587_bb0255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MBC.0b013e328347404d","article-title":"Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay","volume":"22","author":"Haas","year":"2011","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"11","key":"10.1016\/j.thromres.2026.109587_bb0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-018-0135-y","volume":"8","author":"Fotiou","year":"2018","journal-title":"Blood Cancer J."},{"issue":"5","key":"10.1016\/j.thromres.2026.109587_bb0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MBC.0b013e3283049639","article-title":"Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis","volume":"19","author":"Sidelmann","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"4","key":"10.1016\/j.thromres.2026.109587_bb0270","first-page":"1128","article-title":"Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer","volume":"109","author":"Englisch","year":"2024","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.thromres.2026.109587_bb0275","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1538-7836.2003.00306.x","article-title":"Thrombomodulin","volume":"1","author":"Weiler","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109587_bb0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OTT.S281251","article-title":"Aberrant factors of fibrinolysis and coagulation in pancreatic cancer","volume":"14","author":"Fang","year":"2021","journal-title":"Onco. Targets. Ther."},{"issue":"2","key":"10.1016\/j.thromres.2026.109587_bb0285","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/bloodadvances.2020003149","article-title":"Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer","volume":"5","author":"Hisada","year":"2021","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.thromres.2026.109587_bb0290","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/jth.15773","article-title":"The role of VWF\/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies","volume":"20","author":"Comerford","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2026.109587_bb0295","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/ATVBAHA.113.303016","article-title":"von Willebrand factor directly interacts with DNA from neutrophil extracellular traps","volume":"34","author":"Grassle","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2026.109587_bb0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2024.03.022","article-title":"Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer","volume":"237","author":"Kawano","year":"2024","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0305","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cyto.2013.02.017","article-title":"IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients","volume":"62","author":"Malaponte","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.thromres.2026.109587_bb0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","article-title":"Neutrophil extracellular traps in cancer","volume":"79","author":"Cristinziano","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109587_bb0315","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","article-title":"Mechanisms and consequences of endothelial cell senescence","volume":"20","author":"Bloom","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"10.1016\/j.thromres.2026.109587_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145168","article-title":"Covid-19: the rollercoaster of fibrin(ogen), D-dimer, Von Willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes","volume":"21","author":"Grobler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.thromres.2026.109587_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247436","article-title":"Correlation of biomarkers of endothelial injury and inflammation to outcome in hospitalized COVID-19 patients","volume":"11","author":"Munguia","year":"2022","journal-title":"J. Clin. Med."},{"issue":"19","key":"10.1016\/j.thromres.2026.109587_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38831","article-title":"Blood hypercoagulability and thrombosis mechanisms in cancer patients -a brief review","volume":"10","author":"Peng","year":"2024","journal-title":"Heliyon"},{"issue":"22","key":"10.1016\/j.thromres.2026.109587_bb0335","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2003.05.165","article-title":"Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism","volume":"21","author":"Goldenberg","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2026.109587_bb0340","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620971041","article-title":"Diagnostic and prognostic value of TAT, PIC, TM, and t-PAIC in malignant tumor patients with venous thrombosis","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.thromres.2026.109587_bb0345","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.thromres.2026.109587_bb0350","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3324\/haematol.12331","article-title":"Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH case-control study","volume":"93","author":"Lacut","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.thromres.2026.109587_bb0355","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/rheumatology\/kew036","article-title":"Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study","volume":"55","author":"Lee","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.thromres.2026.109587_bb0360","doi-asserted-by":"crossref","DOI":"10.7326\/J23-0099","article-title":"NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic disease","volume":"176","author":"Parks","year":"2023","journal-title":"Ann. Intern. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482600006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482600006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:18:10Z","timestamp":1781943490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482600006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":72,"alternative-id":["S004938482600006X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109587","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation parameters in gastrointestinal cancer patients with venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109587"}}